Kindbody, a New York-based women’s healthcare tech startup, announced it has raised $15 million in Series A funding. Including this round, Kindbody has raised $22 million. This round of funding was co-led by RRE Ventures and Perceptive Advisors.
New and existing investors Green D Ventures, Trail Mix Ventures, and Winklevoss Capital also participated in this round. In conjunction with this round, Ellen Hukkelhoven of Perceptive Advisors and Alice Lloyd George of RRE is joining Kindbody’s board.
Kindbody is reinventing women’s healthcare through its brick-and-mortar and mobile clinics. These clinics offer fertility care, mental health support, nutrition, and gynecological services. The Kindbody team includes founder and CEO Gina Bartasi, Chief Medical Officer (REI) Dr. Lynn Westphal of the Stanford University School of Medicine, co-founder and head of product Joanne Schneider, founding physician Dr Fahimeh Sasan, and SVP of Business and Legal Affairs Shilpa Patel.
“As a women’s health company, we knew our ideal lead investors would be women and from NYC. We’re appreciative of the support and infrastructure that a city like New York provides us,” said Bartasi. “We’re passionate about delivering a better solution and we only get there through the support of our female-led investors, female-led leadership team and incredibly supportive female patient population.”
Kindbody has seen hundreds of women in three markets including NY, LA, and San Francisco through brick-and-mortar and mobile units since it launched in August 2018. And additional locations are opening soon. The upcoming locations are predominantly retail-level and a flagship location in Manhattan at 102 Fifth Avenue will be opening this summer.
“We were excited about Kindbody from the moment we met the team,” added George. “We believe in their vertically-integrated and patient-centric approach. Demand is growing rapidly and there’s a huge gap in this market – the timing couldn’t be better to build a trusted, national brand that speaks to millennials and is fundamentally democratizing access to care.”
Recently, Kindbody announced it would be providing fertility benefits directly to employers in order to help reduce costs and increase transparency. Through its services, Kindbody is offering a one-stop solution for all reproductive care needs including testing, assessment, full fertility services (IVF, IUI and egg freezing), nutrition, and pre- and post-partum care. As a result, this removes the burden on patients from having to navigate on their own and makes it easier for employers having to decide between various bifurcated solutions.
“The women’s health sector has long been underserved – by both investment and technology. We’ve been following Kindbody since the beginning and their ability to scale and utilize technology to improve decision making and efficiencies is what led to our investment,” explained Hukkelhoven. “In the midst of a new wave of feminism, we are excited to partner with Kindbody to deliver female empowerment through data-enabled healthcare.”Some of Kindbody’s previous investors include TQ Ventures, Chelsea Clinton and Marc Mezvinsky, Nat Turner (Flatiron Health co-Founder and CEO), Vivek Garipalli (Clover Health co-founder and CEO), Marco DeMeireles (Partner at TCG), Leandra Medine (founder of Man Repeller), and Halle Tecco (Founder Emeritus of Rock Health).
